Caspar I. van der Made

1.6k total citations
13 papers, 292 citations indexed

About

Caspar I. van der Made is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Caspar I. van der Made has authored 13 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Caspar I. van der Made's work include Immunodeficiency and Autoimmune Disorders (5 papers), Genomics and Rare Diseases (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Caspar I. van der Made is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (5 papers), Genomics and Rare Diseases (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Caspar I. van der Made collaborates with scholars based in Netherlands, United States and Germany. Caspar I. van der Made's co-authors include Alexander Hoischen, Mihai G. Netea, Frank L. van de Veerdonk, Annet Simons, Helen L. Leavis, Ruud G.L. de Sévaux, Abraham Rutgers, Pieter van Paassen, Mariëlle van Gijn and Arjan J. Kwakernaak and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Immunological Reviews and Frontiers in Immunology.

In The Last Decade

Caspar I. van der Made

10 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caspar I. van der Made Netherlands 6 122 97 96 93 55 13 292
Lindsay E. Nyhoff United States 10 29 0.2× 49 0.5× 127 1.3× 93 1.0× 46 0.8× 14 277
Karima Yacouben France 7 104 0.9× 24 0.2× 30 0.3× 136 1.5× 37 0.7× 12 341
Pablo Chicharro Spain 9 54 0.4× 50 0.5× 48 0.5× 24 0.3× 27 0.5× 23 221
Yusuf Patel United Kingdom 7 71 0.6× 97 1.0× 149 1.6× 12 0.1× 37 0.7× 13 277
Houria Hendel‐Chavez France 5 155 1.3× 30 0.3× 72 0.8× 47 0.5× 22 0.4× 7 252
J. Kurtzberg United States 3 31 0.3× 52 0.5× 39 0.4× 273 2.9× 64 1.2× 9 368
Christoph Rietschel Germany 8 49 0.4× 41 0.4× 153 1.6× 17 0.2× 140 2.5× 16 305
À. Olivé Spain 7 103 0.8× 18 0.2× 34 0.4× 42 0.5× 17 0.3× 13 175
S. K. China 11 28 0.2× 24 0.2× 46 0.5× 61 0.7× 85 1.5× 23 337
Klaus Rehe Germany 7 65 0.5× 12 0.1× 34 0.4× 41 0.4× 61 1.1× 11 239

Countries citing papers authored by Caspar I. van der Made

Since Specialization
Citations

This map shows the geographic impact of Caspar I. van der Made's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caspar I. van der Made with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caspar I. van der Made more than expected).

Fields of papers citing papers by Caspar I. van der Made

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caspar I. van der Made. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caspar I. van der Made. The network helps show where Caspar I. van der Made may publish in the future.

Co-authorship network of co-authors of Caspar I. van der Made

This figure shows the co-authorship network connecting the top 25 collaborators of Caspar I. van der Made. A scholar is included among the top collaborators of Caspar I. van der Made based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caspar I. van der Made. Caspar I. van der Made is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Potjewijd, Judith, Hans J. P. M. Koenen, Caspar I. van der Made, et al.. (2025). A novel missense variant in TNFAIP3 associated with autoimmunity reveals the contribution of STAT1/mTOR pathways. Clinical & Experimental Immunology. 219(1).
2.
Made, Caspar I. van der, Simone Kersten, Musa M. Mhlanga, et al.. (2024). Multi-omic profiling of pathogen-stimulated primary immune cells. iScience. 27(8). 110471–110471.
3.
Sahajpal, Nikhil, Alex Hastie, Maximilian Schieck, et al.. (2023). Genetic Predisposition to Neurological Complications in Patients with COVID-19. Biomolecules. 13(1). 133–133.
4.
Made, Caspar I. van der, Rutger J. Röring, Georgia Damoraki, et al.. (2023). Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients. Frontiers in Immunology. 14. 1233318–1233318. 15 indexed citations
5.
Arts, Rob J.W., Caspar I. van der Made, M. Hendriks, et al.. (2023). OTULIN Haploinsufficiency-Related Fasciitis and Skin Necrosis Treated by TNF Inhibition. Journal of Clinical Immunology. 44(1). 10–10. 4 indexed citations
6.
Saraiva-Agostinho, Nuno, Caspar I. van der Made, Simone Kersten, et al.. (2023). SUsPECT: a pipeline for variant effect prediction based on custom long-read transcriptomes for improved clinical variant annotation. BMC Genomics. 24(1). 305–305. 1 indexed citations
7.
Simons, Annet, Janneke Schuurs-Hoeijmakers, Evelien Zonneveld‐Huijssoon, et al.. (2022). Trio-based whole exome sequencing in patients with suspected sporadic inborn errors of immunity: A retrospective cohort study. eLife. 11. 4 indexed citations
8.
Made, Caspar I. van der, Viola Klück, Annet Simons, et al.. (2022). Effect of exogenous IL-37 on immune cells from a patient carrying a potential IL37 loss-of-function variant: A case study. Cytokine. 162. 156102–156102. 1 indexed citations
9.
Made, Caspar I. van der, et al.. (2022). Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19. Genome Medicine. 14(1). 96–96. 36 indexed citations
10.
Hoischen, Alexander, et al.. (2021). Next-Generation Sequencing in the Field of Primary Immunodeficiencies: Current Yield, Challenges, and Future Perspectives. Clinical Reviews in Allergy & Immunology. 61(2). 212–225. 20 indexed citations
11.
Made, Caspar I. van der, Judith Potjewijd, Huub P J Willems, et al.. (2021). Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS. Journal of Allergy and Clinical Immunology. 149(1). 432–439.e4. 128 indexed citations
12.
Solanich, Xavier, Gardenia Vargas‐Parra, Caspar I. van der Made, et al.. (2021). Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19. Frontiers in Immunology. 12. 719115–719115. 74 indexed citations
13.
Made, Caspar I. van der, Alexander Hoischen, Mihai G. Netea, & Frank L. van de Veerdonk. (2020). Primary immunodeficiencies in cytosolic pattern‐recognition receptor pathways: Toward host‐directed treatment strategies. Immunological Reviews. 297(1). 247–272. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026